tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRNX Stock Latest News

Trump threatens new tariffs on drugs, kitchen cabinets, trucks: Morning Buzz
The FlyTrump threatens new tariffs on drugs, kitchen cabinets, trucks: Morning Buzz
1d ago
W
HD
Crinetics rises 25.7%
PremiumThe Fly
Crinetics rises 25.7%
1d ago
CRNX
Crinetics rises 21.9%
PremiumThe Fly
Crinetics rises 21.9%
1d ago
CRNX
Crinetics price target raised to $62 from $58 at Baird
PremiumThe Fly
Crinetics price target raised to $62 from $58 at Baird
2d ago
CRNX
Buy Rating for Crinetics Pharmaceuticals Driven by FDA Approval and Strategic Market Positioning of Palsonify
PremiumRatings
Buy Rating for Crinetics Pharmaceuticals Driven by FDA Approval and Strategic Market Positioning of Palsonify
2d ago
CRNX
Crinetics Pharmaceuticals Gains FDA Approval for PALSONIFY
PremiumCompany AnnouncementsCrinetics Pharmaceuticals Gains FDA Approval for PALSONIFY
2d ago
8K
CRNX
Crinetics price target raised to $143 from $86 at Citizens JMP
Premium
The Fly
Crinetics price target raised to $143 from $86 at Citizens JMP
2d ago
CRNX
Crinetics announces FDA approval of PALSONIFY
Premium
The Fly
Crinetics announces FDA approval of PALSONIFY
2d ago
CRNX
Crinetics Pharmaceuticals trading halted, news pending
PremiumThe Fly
Crinetics Pharmaceuticals trading halted, news pending
2d ago
CRNX
Crinetics price target lowered to $52 from $53 at JPMorgan
PremiumThe Fly
Crinetics price target lowered to $52 from $53 at JPMorgan
4d ago
CRNX
Crinetics management to meet with Cantor Fitzgerald
PremiumThe Fly
Crinetics management to meet with Cantor Fitzgerald
5d ago
CRNX
Crinetics receives Orphan Drug designation for atumelnant in CAH
PremiumThe Fly
Crinetics receives Orphan Drug designation for atumelnant in CAH
1M ago
CRNX
Crinetics’ treatment of CAH granted FDA orphan designation
PremiumThe FlyCrinetics’ treatment of CAH granted FDA orphan designation
1M ago
CRNX
Crinetics Pharma’s Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Crinetics Pharma’s Earnings Call: Progress Amid Challenges
2M ago
CRNX
Crinetics Pharmaceuticals: A Promising Buy with Strategic Initiatives and Upcoming Milestones
Premium
Ratings
Crinetics Pharmaceuticals: A Promising Buy with Strategic Initiatives and Upcoming Milestones
2M ago
CRNX
Crinetics price target lowered to $86 from $90 at Citizens JMP
PremiumThe Fly
Crinetics price target lowered to $86 from $90 at Citizens JMP
2M ago
CRNX
Crinetics Pharmaceuticals Reports Q2 2025 Financial Results
PremiumCompany Announcements
Crinetics Pharmaceuticals Reports Q2 2025 Financial Results
2M ago
CRNX
Crinetics Pharmaceuticals: Promising Outlook with Anticipated Approval of Palsonify and Strategic Market Launch
PremiumRatings
Crinetics Pharmaceuticals: Promising Outlook with Anticipated Approval of Palsonify and Strategic Market Launch
2M ago
CRNX
Crinetics reports Q2 EPS ($1.23), consensus ($1.10)
PremiumThe Fly
Crinetics reports Q2 EPS ($1.23), consensus ($1.10)
2M ago
CRNX
3 Best Stocks to Buy Now, 7/22/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 7/22/2025, According to Top Analysts
2M ago
BLZE
CRNX
Crinetics Pharmaceuticals’ Palsonify Gains Positive Endorsement for Acromegaly Treatment with Promising Pipeline Expansion
Premium
Ratings
Crinetics Pharmaceuticals’ Palsonify Gains Positive Endorsement for Acromegaly Treatment with Promising Pipeline Expansion
2M ago
CRNX
Crinetics Pharmaceuticals: Promising Pipeline and Strategic Advancements Justify Buy Rating
Premium
Ratings
Crinetics Pharmaceuticals: Promising Pipeline and Strategic Advancements Justify Buy Rating
2M ago
CRNX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >